Husnu Ümit Kaniskan

28PUBLICATIONS
109CO-AUTHORS
Predictive and prognostic markersMedical devicesMolecular and organic electronicsHaematological tumoursMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Aug 14, 2026
An EZH2-SREBP2 axis promotes cholesterol biosynthesis and represents a noncanonical vulnerability in tumorigenesis.

|Apr 23, 2026
Discovery of a Highly Potent and Selective ENL Degrader.

|Apr 17, 2026
Structural and biochemical characterization of a novel inhibitor of NMNAT1, the gatekeeper of nuclear NAD+ biosynthesis.

|Aug 22, 2025
SOX11 modulates BCR signaling through the PAX5/CD19 axis for therapeutic targeting in BTK-resistant mantle cell lymphoma.

Rudra Prasad Dutta, Heng-Huan Lee, Violetta V Leshchenko

|Apr 23, 2025
Pharmacologic degradation of WDR5 suppresses oncogenic activities of SS18::SSX and provides a therapeutic of synovial sarcoma.

Yao Yu, Xufen Yu, Bo Pan

|Apr 08, 2025
Design and validation of novel brain-penetrant HCN channel inhibitors to ameliorate social stress-induced susceptible phenotype.

Emily M Teichman, Jianping Hu, Hsiao-Yun Lin

Pageof 5

Frequent Collaborators

26 joint publications

Jian Jin

7 joint publications

Wenyi Wei

5 joint publications

Gang Greg Wang

5 joint publications

Xufen Yu